Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ARRIA NLG PLC. We currently have 8 research reports from 2 professional analysts.
|19Jan17 07:00||RNS||Company update|
|06Jan17 10:32||RNS||Result of General Meeting|
|19Dec16 07:00||RNS||Proposed cancellation of trading on AIM|
|07Dec16 07:00||RNS||Holding(s) in Company|
|01Dec16 08:45||RNS||Timetable and Progress to NZ and Australia IPO|
|21Nov16 08:00||RNS||Update on Loan Note Subscriptions|
|07Nov16 16:35||RNS||Price Monitoring Extension|
Frequency of research reports
Research reports on
ARRIA NLG PLC
ARRIA NLG PLC
31 Aug 16
Crossword Cybersecurity *(ISDX:CCS) | Goldplat (GDP.L) | Benchmark Holdings (BMK.L) | FairFX Group (FFX.L) | Arria NLG (NLG.L) | Quantum Pharma (QP.L) | Taptica International (TAP.L) | Hummingbird Resources (HUM.L) | Surgical Innovations Group (SUN.L) | Eurasia Mining (EUA.L)
Progress on Genpact partnership
12 Apr 16
Arria has announced this morning that its technology partner Genpact has moved three NLG applications to the next phase of their development. They are known as: 1) Model Documentation and Validation, 2) Financial Planning and Analysis (FP&A) Reporter, and 3) Credit Assessment. Genpact works with Arria to provide financial planning and analysis services, and we see today’s announcement as validation and vindication of Arria’s technology in this field. Building on other recent positive news flow, this indicates that the business continues to gain traction.
Earnings upgrade following acquisition
17 Apr 17
Following the recent acquisition of Ingresso we upgrade our estimates by c10% in 2017. Ingresso owns and operates a software platform which enables sales through global third party distribution channels. This looks another smart acquisition by ACSO who continue to create a more efficient flow in the extremely fragmented leisure and ticketing industry. We increase our T/P to 2000p and upgrade to BUY.
N+1 Singer - Servelec Group - Calling the bottom
20 Apr 17
We are increasingly confident that Servelec’s travails are behind it and the business is returning to growth. Recent share price weakness looks unwarranted in this context and the valuation now looks compelling. Our forecasts are essentially unchanged, but we see medium term upside as the group’s markets improve. Servelec remains a key idea for 2017 and we reiterate our Buy recommendation and 325p Target Price.
N+1 Singer - Morning Song 24-04-2017
24 Apr 17
First Derivatives (FDP LN) FY slightly ahead as strong trading momentum continues | Goals Soccer Centres (GOAL LN) A potentially exciting corporate development | mporium Group (MPM LN) 2016 results: course set for exciting 2017 | Vectura Group (VEC LN) VR315 risk outweighs longer-term potential
Pickup in H2 organic growth as expected
20 Apr 17
Headline revenue growth of 19% reflects a full half contribution of ID Scan and a pickup in organic growth to 12% across the year driven by the excellent performance from the higher margin international services. The mix effects of this growth resulted in EBIT of £17m, 4% ahead of our forecasts, and a 1.1pp improvement in the operating margin.
19 Apr 17
Lombard Risk Management* (LRM): Beats demanding growth and profit forecasts (CORP) | Frontier Developments* (FDEV): Steaming ahead (CORP) | Tax Systems* (TAX): Right place, right time (CORP) | Acal (ACL): Stronger H2 and brighter outlook (BUY) | Fenner (FENR): Interim results signal upgrades (BUY) | Minds + Machines* (MMX): US and Europe domain sales (CORP)